Discovery and Biosynthetic Interrogation of a Cobalt-Containing Terpene-Polyketide-Nonribosomal Peptide Tribrid with Anticoronavirus Activity
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c16450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Dan Xue und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, Texas 78712, United States. Hauptthemen laut MEDLINE: Cobalt, Antiviral Agents, SARS-CoV-2, Terpenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, University of Pittsburgh.
Abstract (Originalsprache)
The structural complexity of natural products arises from the complexity of their biosynthetic pathways and directly contributes to their biological activities. Guided by this principle, we screened 500 microbial extracts using high-throughput screening to identify structurally novel inhibitors of coronavirus main protease, 3CLpro. We discovered and structurally characterized a new scaffold, cobaltribin, the only isolated cobalt-containing natural product except vitamin B12 cobalamins. We further analyzed cobaltribin analogs to expand this unique class of anticoronavirus compounds. Furthermore, evidence from our bioinformatic, isotope labeling, and gene deletion analyses suggested that cobaltribin is a tribrid natural product resulting from an unprecedented terpene-polyketide (PK)-nonribosomal peptide (NRP) trihybridized biosynthesis. Notably, cobaltribin inhibits live severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in infected Vero E6 cells without toxicity to the host, demonstrating its promise as a therapeutic candidate against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, University of Texas at Austin, Austin, Texas 78712, United States.
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina 29208, United States.
- Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.
- Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, United States.
- Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, South Carolina 29209, United States.
- Pharmaceutical Sciences Division, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- University of Pittsburgh
- National Institutes of Health
Zitieren
APA
Xue, D., Wu, Q., Hou, L., Pulliam, C., Xu, M., Madden, M. D., Madu, J., Li, Y., Liu, S., Fan, D., Bugni, T. S., Wang, T., & Li, J. (2025). Discovery and Biosynthetic Interrogation of a Cobalt-Containing Terpene-Polyketide-Nonribosomal Peptide Tribrid with Anticoronavirus Activity. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c16450
Vancouver
Xue D, Wu Q, Hou L, Pulliam C, Xu M, Madden MD, et al. Discovery and Biosynthetic Interrogation of a Cobalt-Containing Terpene-Polyketide-Nonribosomal Peptide Tribrid with Anticoronavirus Activity. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c16450
BibTeX
@article{Xue2025,
author = {Xue, Dan and Wu, Qihao and Hou, Lukuan and Pulliam, Conor and Xu, Mingming and Madden, Michael D and Madu, Joshua and Li, Ying and Liu, Shufeng and Fan, Daping and Bugni, Tim S and Wang, Tony and Li, Jie},
title = {Discovery and Biosynthetic Interrogation of a Cobalt-Containing Terpene-Polyketide-Nonribosomal Peptide Tribrid with Anticoronavirus Activity},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c16450}
}
EUVIMED